Clinical Trials Logo

Sore Throat clinical trials

View clinical trials related to Sore Throat.

Filter by:

NCT ID: NCT01052038 Completed - Pain Clinical Trials

Post Operative Sore Throat and Dexamethasone

Start date: January 2010
Phase: Phase 4
Study type: Interventional

Sore throat is a common postoperative complaint that can lead to morbidity and patient dissatisfaction . The incidence of sore throat has been reported to be between 6% and 90% even under optimal intubating conditions. There are several factors that have been shown to contribute to postoperative sore throat such as patient related factors, type of anesthesia and type of surgery. Corticosteroids are also commonly used in the perioperative period to potentiate analgesics and as antiemetics. The preoperative administration of dexamethasone can decrease the incidence and severity of postoperative sore throat which is rated by patients as one of the most undesirable outcomes in the postoperative period.

NCT ID: NCT01033799 Completed - Influenza Clinical Trials

Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers

Start date: October 2006
Phase: N/A
Study type: Interventional

This single-center, randomized, double-blind and controlled study aims to examine the effect of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common infectious diseases (cumulated number of infections during the intervention period: primary criteria), and on immune functions in healthy shift workers. Volunteers received either 200g/day of tested product (N=500) or control product (N=500) for 3-months, followed by a 1-month follow-up.

NCT ID: NCT00957996 Completed - Fatigue Clinical Trials

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Start date: October 2009
Phase: Phase 3
Study type: Interventional

This is a Phase 3, open-label, randomized study of the antiviral activity, safety, and tolerability of intravenous Peramivir in hospitalized subjects with confirmed or suspected influenza infection.

NCT ID: NCT00242281 Completed - Sore Throat Clinical Trials

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of APC 111 MP Tablet, 775 mg tablet, given orally (PO)once daily (QD) for 10 days compared to that of Penicillin VK, 250 mg PO four times daily (QID) for 10 days in terms of bacteriological outcome at the Test-of-Cure (TOC) Visit (Day 14-18) in the eligible Per-Protocol bacteriological (PPb) population.